In last trading session, Puma Biotechnology Inc (NASDAQ:PBYI) saw 0.39 million shares changing hands with its beta currently measuring 1.09. Company’s recent per share price level of $4.86 trading at -$0.1 or -2.02% at ring of the bell on the day assigns it a market valuation of $234.30M. That closing price of PBYI’s stock is at a discount of -59.05% from its 52-week high price of $7.73 and is indicating a premium of 56.17% from its 52-week low price of $2.13. Taking a look at company’s average trading volume volume of 585.20K if we extend that period to 3-months.

Puma Biotechnology Inc (NASDAQ:PBYI) trade information

Upright in the red during last session for losing -2.02%, in the last five days PBYI remained trading in the red while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $4.86 price level, adding 7.6% to its value on the day. Puma Biotechnology Inc’s shares saw a change of 12.24% in year-to-date performance and have moved -3.19% in past 5-day. Puma Biotechnology Inc (NASDAQ:PBYI) showed a performance of -11.80% in past 30-days.

Puma Biotechnology Inc (PBYI) estimates and forecasts

Statistics highlight that Puma Biotechnology Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 83.40% of value to its shares in past 6 months, showing an annual growth rate of -23.88% while that of industry is 12.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

PBYI Dividends

Puma Biotechnology Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.